Journal Mobile Options
Table of Contents
Vol. 133, No. 2, 2004
Issue release date: February 2004
Int Arch Allergy Immunol 2004;133:168–173
(DOI:10.1159/000076623)

Wheat Allergy: Clinical and Laboratory Findings

Pourpak Z. · Mansouri M. · Mesdaghi M. · Kazemnejad A. · Farhoudi A.
aImmunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, and bDepartment of Biostatistics, School of Medicine, Tarbiat Modares University, Tehran, Iran

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Food allergy affects 6–8% of infants and wheat allergy is one of the common food allergies among children. The clinical and laboratory manifestations of wheat allergy were evaluated in this study. Methods: Thirty-two children (≤12 years old) with suspected wheat allergy were evaluated for wheat allergy. The patients underwent wheat skin prick test (SPT), measurement of wheat-specific IgE and wheat challenge test. The patients with a convincing history of anaphylaxis following ingestion of wheat or with a positive challenge test, and those with a history of immediate hypersensitivity reaction following ingestion of wheat in addition to a positive wheat SPT and/or positive wheat-specific IgE were considered wheat allergic. Then, the laboratory and clinical manifestations of their disease were studied. Results: Among patients with suspected wheat allergy, 24 patients with definite wheat allergy were identified. Anaphylaxis was a dominant clinical feature, accounting for 54.1% of acute symptoms. Chronic allergy symptoms like asthma and eczema were noted in 50% of the patients. Wheat-specific IgE was higher in patients with anaphylaxis (p < 0.02) and the risk of anaphylaxis was 14.4 times more in patients with wheat-specific IgE equal to or more than 3+. Conclusions: Anaphylaxis had occurred in a remarkable number of patients repeatedly, which demonstrates the severity of the reactions, poor knowledge of the disease and probable existence of more patients with mild reactions. Regarding the higher level of wheat-specific IgE in patients with anaphylaxis, wheat-specific IgE could be used to predict the severity of symptoms.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Sicherer SH, Sampson HA: Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999;104:S114–122.
  2. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA: Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998;101:E8.
  3. Bock SA: Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987;79:683–688.
  4. Sicherer SH: Manifestations of food allergy: Evaluation and management. Am Fam Physician 1999;59:415–424, 429–430.
  5. Sampson HA: Adverse reactions to foods; in Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW (eds): Allergy Principles and Practice. St Louis, Mosby, 1998, vol 2, pp 1162–1182.
  6. Burks AW, James JM, Hiegel A, Wilson G, Wheeler JG, Jones SM, Zuerlein N: Atopic dermatitis and food hypersensitivity reactions. J Pediatr 1998;132:132–136.
  7. Kulig M, Bergmann R, Niggemann B, Burow G, Wahn U: Prediction of sensitization to inhalant allergens in childhood: Evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study. Clin Exp Allergy 1998;28:1397–1403.
  8. Nakase M, Usui Y, Alvarez-Nakase AM, Adachi T, Urisu A, Nakamura R, Aoki N, Kitajima K, Matsuda T: Cereal allergens: Rice-seed allergens with structural similarity to wheat and barley allergens. Allergy 1998;53(46 suppl):55–57.
  9. Sampson HA, McCaskill CC: Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients. J Pediatr 1985;107:669–675.
  10. Sampson HA, Ho DG: Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444–451.
  11. James JM, Sixbey JP, Helm RM, Bannon GA, Burks AW: Wheat alpha-amylase inhibitor: A second route of allergic sensitization. J Allergy Clin Immunol 1997;99:239–244.
  12. James JM, Sampson HA: An overview of food hypersensitivity. Pediatr Allergy Immunol 1992;3:67–78.
  13. Jones SM, Sampson HA: The role of allergens in atopic dermatitis; in Leung DYM (ed): Atopic Dermatitis: From Pathogenesis to Treatment. Texas, Landes, 1996.
  14. Varjonen E, Vainio E, Kalimo K: Life-threatening, recurrent anaphylaxis caused by allergy to gliadin and exercise. Clin Exp Allergy 1997;27:162–166.

    External Resources

  15. Blands J, Diamant B, Kallos P, Kallos-Deffner L, Lowenstein H: Flour allergy in bakers. Identification of allergenic fractions in flour and comparison of diagnostic methods. Int Arch Allergy Appl Immunol 1976;52:392–406.
  16. Sturgess RP, Ellis HJ, Ciclitira PJ: Cereal chemistry, molecular biology, and toxicity in coeliac disease. Gut 1991;32:1055–1060.
  17. Armentia A, Martin-Santos JM, Blanco M, Carretero L, Puyo M, Barber D: Exercise-induced anaphylactic reaction to grain flours. Ann Allergy 1990;65:149–151.
  18. Lim KG, Weller PF: Eosinophilia and eosinophil-related disorders; in Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW (eds): Allergy Principles and Practice. St Louis, Mosby, 1998, vol 2, pp 783–798.
  19. Ownby DR: In vitro assays for the evaluation of immunologic reactions to foods. Immunol Allergy Clin North Am 1991;11:851–857.
  20. Sly M: Allergic disorders; in Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics. Philadelphia, Saunders, 2000, p 651.
  21. Bock SA, Sampson HA, Atkins FM, Zeiger RS, Lehrer S, Sachs M, Bush RK, Metcalfe DD: Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual. J Allergy Clin Immunol 1988;82:986–997.
  22. Bahna SL: Practical considerations in food challenge testing. Immunol Allergy Clin North Am 1991;11:843–851.
  23. Pearlman DS, Bierman CW: Immunologic aspects of pediatric illnesses; in Stiehm ER (ed): Immunologic Disorders in Infants and Children. Philadelphia, Saunders, 1996, pp 603–641.
  24. Durham SR, Church MK: Principles of allergy diagnosis; in Holgate ST, Church MK, Lichtenstein LM (eds): Allergy. St Louis, Mosby, 2001, pp 1–16.
  25. Metcalfe DD, Sampson HA: Workshop on experimental methodology for clinical studies of adverse reactions to foods and food additives. J Allergy Clin Immunol 1990;86:421–442.
  26. Demoly P, Michel FB, Bousquet J: In vivo methods for study of allergy, techniques and interpretation; in Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW (eds): Allergy Principles and Practice. St Louis, Mosby, 1998, vol 1, pp 430–439.
  27. Sampson HA: Food allergy. 2. Diagnosis and management. J Allergy Clin Immunol 1999;103:981–989.
  28. Taylor SL, Hefle SL: Foods as allergens; in Brostoff J, Challacombe SJ (eds): Food Allergy and Intolerance. Philadelphia, Saunders, 2002, pp 403–412.
  29. Takizawa T, Arakawa H, Tokuyama K, Morikawa A: Identification of allergen fractions of wheat flour responsible for anaphylactic reactions to wheat products in infants and young children. Int Arch Allergy Immunol 2001;125:51–56.
  30. Reibel S, Rohr C, Ziegert M, Sommerfeld C, Wahn U, Niggemann B: What safety measures need to be taken in oral food challenges in children? Allergy 2000;55:940–944.
  31. Green R, Luyt D: Clinical characteristics of childhood asthmatics in Johannesburg. S Afr Med J 1997;87:878–882.
  32. Eslamnour A, Pourpak Z, Farhoudi A, Movahedi M, Gharagozlou M, Farzaneh P, Omidi Z: The relationship between serum total IgE level and eosinophil count with the severity of atopic dermatitis (abstract). Allergy Clin Immunol Int 2000(suppl 2):191.
  33. Gerrard JW: Cow’s milk and breast milk; in Brostoff J, Challacombe SJ (eds): Food Allergy and Intolerance. Philadelphia, Saunders, 2002, pp 435–444.
  34. Sampson HA: Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001;107:891–896.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50